Delivery Order SPE2DB22D2206-SPE2DB24FES98
Award Date 12/20/23
Potential Completion Date 12/21/23
Potential Value $3.8K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide AMBISOME 50 MG VIALS. The $1,923.48 award is for pharmaceutical products to support military treatment programs and facilities, with a completion date of December 28, 2023. Amerisourcebergen Drug Corp, through its Corporate Office division, has a long history of providing pharmaceuticals, medical supplies, and related...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, as the prime contractor. The $4,318.10 firm fixed price delivery order is for the supply of AMBISOME 50 MG VIALS, a pharmaceutical product, with a period of performance through April 2, 2024. This award is associated with a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued up to $999,999,999.00...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 50 mg vials of the pharmaceutical product AmBisome. The contract has a completion date of February 16, 2024 and a potential value of $2,517.84. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of...
- The Defense Logistics Agency awarded a $21,536.98 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of 50 mg vials of Ambisome on December 1, 2025, with an ultimate completion date of December 2, 2025. This competitive award, issued without set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, to provide AmBisome 50 mg vials. The contract has a ceiling value of $2,517.84 and a performance period through March 28, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for the company to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,720.51 to AmerisourceBergen Drug Corp for the supply of AmBisome 50 mg vials. This firm fixed price, competitively awarded delivery order is scheduled for completion by December 5, 2025, with performance at the company's corporate headquarters in Conshohocken, Pennsylvania. AmBisome is a liposomal amphotericin B formulation used for treating serious fungal infections, representing a critical pharmaceutical commodity for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of AmBisome 50 mg vials, a critical antifungal medication used in military and federal healthcare systems. This competitively awarded, non-set-aside contract is valued at $16,184.74 with a firm fixed price structure and an ultimate completion date of August 5, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 1, 2025, for the supply of AmBisome 50 mg vials, a specialized antifungal pharmaceutical product. This competitively awarded, non-set-aside contract carries a ceiling value of $7,741.00 with firm fixed pricing and an ultimate completion date of September 2, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- This federal contract award is for the delivery of AMBISOME 50 MG VIALS to the Defense Logistics Agency (DLA). The $1,923.48 firm fixed price delivery order was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., which serves as the primary vehicle for the company to supply a comprehensive range...
- This federal contract award is for the delivery of AmBisome 50 mg vials, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,923.48 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., holds with the DLA Troop...